The GeneSight test analyzes clinically important genetic variations in your DNA. The results of the test can inform your doctor about genes that may impact how you metabolize or respond to certain ...
“Treatment decisions for people with major depressive disorder are challenging, particularly for patients who have already not benefitted from one or more medications,” said Michael E. Thase M.D., ...
SALT LAKE CITY, April 09, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, revealed results from a multi-year, real-world study of ...
Myriad Genetics, Inc., a leader in molecular diagnostic testing and precision medicine, today announced a post-hoc analysis of the Precision Medicine in Mental Health Care (PRIME) study showed that ...
SALT LAKE CITY, April 21, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc (MYGN). (NASDAQ: MYGN), a leader in molecular diagnostics testing and precision medicine, today announced that the Journal of ...
SALT LAKE CITY, Oct. 30, 2025 – Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced a post-hoc analysis of the Precision Medicine in ...
“For three years, it was like throwing darts at a dartboard – except, I was the dartboard,” said Ronni, whose acute suffering persisted as she and her health care providers searched for medication to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results